Pediatric and Ambulatory Research in Infectious Diseases
Launched by ASSOCIATION CLINIQUE THÉRAPEUTIQUE INFANTILE DU VAL DE MARNE · Jul 10, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Pediatric and Ambulatory Research in Infectious Diseases," is studying common infections in children, such as ear infections, colds, and stomach bugs. The goal is to create a network that helps doctors better understand and treat these illnesses by providing them with special training, using quick testing methods, and collecting data from their computers. This research will help improve how pediatricians care for children with these infections.
To participate in this study, children under 16 years old who have been diagnosed with one or more of the listed infections, like pneumonia or influenza, may be eligible. The study is currently recruiting participants, and the only reason a child might not be able to join is if a parent decides not to participate. If you choose to take part, you can expect to work with trained pediatricians who will collect information about your child's health, which will ultimately help improve treatment for kids with infectious diseases in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Children under 16 years of age with at least one infectious disease among:
- • pharyngitis
- • otitis
- • pneumonia
- • influenza
- • bronchiolitisz
- • varicella
- • gastroenteritis
- • enterovirus disease
- • bordetella pertussis disease
- • using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)
- Exclusion Criteria:
- • parental refusal
About Association Clinique Thérapeutique Infantile Du Val De Marne
The Association Clinique Thérapeutique Infantile du Val de Marne (ACTIV) is a dedicated clinical trial sponsor focused on advancing pediatric healthcare through innovative research and therapeutic interventions. Based in the Val de Marne region, ACTIV collaborates with healthcare professionals, academic institutions, and regulatory bodies to design and conduct clinical trials that address the unique medical needs of infants and children. With a commitment to ethical practices and patient safety, ACTIV aims to improve treatment outcomes and enhance the quality of life for young patients by translating scientific discoveries into effective clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Créteil, , France
Patients applied
Trial Officials
Robert Cohen
Study Director
Association Clinique et Thérapeutique Infantile du Val de Marne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials